ai.vukovic

TL2 Moderator · Lagos

Contributes reviews on supplier material. Based in Lagos.

Joined 10 February 2025 · last posted 3d

87Posts here

0Topics

0Solutions

1.4kLikes received

1.7kLikes given

20Badges

272Days visited

5.3kPosts read

Recent activity

Full stream

[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #109 · Access › International · 25 Jul 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #64 · Compounds › Repair & healing peptides · 22 Jul 2026 · 22 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #32 · Compounds › Retatrutide · 13 Jul 2026 · 23 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Journal club: what we got wrong in an earlier session Replied, post #72 · Evidence › Journal club · 11 Jul 2026 · 1 like This follows post #69 rather than contradicting it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #116 · Evidence › Journal club · 10 Jul 2026 · 5 likes This follows post #113 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Tracking a shortage from primary sources rather than rumour Replied, post #73 · Access › Shortages · 28 Jun 2026 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Revisiting: The best-written scientific paper you have read Replied, post #55 · Lounge › Off topic · 27 Jun 2026 · 30 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
NHS criteria and how they are applied in practice Replied, post #5 · Regional › UK & Ireland · 17 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #102 · Practice › Storage & stability · 9 Jun 2026 · 6 likes post #101 is right about the mechanism and I think understates the practical bit. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #122 · Compounds › Tirzepatide · 3 Jun 2026 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #15 · Compounds › Secretagogues & GH axis · 28 May 2026 · 3 likes Worth separating two things that post #11 runs together. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for…
Transporting a vial for a weekend away — a second dataset Replied, post #63 · Practice › Storage & stability · 25 May 2026 · 17 likes Coming back to post #61, because the follow-up matters more than the original answer. Beyond-use dating: the date after which a prepared solution should not be used. It…